Edition:
United Kingdom

People: Sihuan Pharmaceutical Holdings Group Ltd (0460.HK)

0460.HK on Hong Kong Stock

1.44HKD
20 Aug 2019
Change (% chg)

HK$-0.04 (-2.70%)
Prev Close
HK$1.48
Open
HK$1.47
Day's High
HK$1.49
Day's Low
HK$1.42
Volume
11,004,500
Avg. Vol
11,849,732
52-wk High
HK$2.22
52-wk Low
HK$1.24

Zhang, Jionglong 

Dr. Zhang Jionglong is Chief Investment Officer, Executive Director of Sihuan Pharmaceutical Holdings Group Ltd. He joined the Company’s management in the Capacity as the head of the Group’s investment department since April 2018. He is in charge of the Group’s investment and mergers and acquisitions. He was first appointed to the Board as a non-executive Director on 18 May 2006 until 8 December 2017. Dr. Zhang has more than 10 years of experience as a medical doctor. From 1983 to 1992, Dr. Zhang worked as a medical doctor in Shenzhen City People’s Hospital, one of the largest hospitals in Shenzhen City, PRC. Dr. Zhang obtained a Graduate Certificate in Medical Treatment from Shantou Medical College, PRC (now known as Shantou University Medical College in 1983. In 1992, Dr. Zhang was conferred the professional title of Chief Physician by the Shenzhen City Title Conferment Reform Leadership Group.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Fengsheng Che

10,017,000

Weicheng Guo

6,023,000

Yiau Chong Choi

1,728,000

Zhongxin Jia

--

Jionglong Zhang

--

Bo Xu

--
As Of  31 Dec 2017